Welcome to our dedicated page for Materialise news (Ticker: MTLS), a resource for investors and traders seeking the latest updates and insights on Materialise stock.
Materialise NV (MTLS) is a Belgium‑headquartered company active in 3D printing and additive manufacturing software. Company press releases and SEC reports describe Materialise as a global leader in 3D‑printed medical devices and software and a pioneer in additive manufacturing software and services. Its news flow reflects both its operational performance and its activities on international capital markets.
On this page, readers can follow Materialise NV news related to its three operating segments: Materialise Medical, Materialise Software, and Materialise Manufacturing. Regular quarterly updates cover revenue, gross profit, segment Adjusted EBITDA, cash position, and other key financial metrics, as well as commentary on macro‑economic conditions affecting the business. Management frequently discusses trends in the Materialise Medical segment and the impact of cost control measures across the group.
In addition to earnings releases, Materialise news includes announcements about shareholder meetings, proposed and approved amendments to the articles of association, and decisions on topics such as share capital movements, buyback authorizations, and remuneration policy. Investors can also track communications about the company’s additional listing on Euronext Brussels, the related listing prospectus, and the launch of an ADS buyback program over Nasdaq.
Because Materialise’s solutions are used in industries such as healthcare, automotive, aerospace, eyewear, art and design, wearables, and consumer goods, its updates often highlight how its software and 3D printing services support industrial manufacturing and mass personalization. For investors and observers interested in additive manufacturing, this news feed offers a consolidated view of Materialise’s financial results, governance decisions, and strategic capital markets actions over time.
Materialise (MTLS) will report fourth-quarter 2025 financial results on Thursday, February 19, 2026 at 2:30 a.m. ET / 8:30 a.m. CET. Senior management will host a conference call and live webcast to discuss results on the same day.
Investors can join the conference call by phone or listen to a live audio webcast at investors.materialise.com; the webcast will be archived on the company website.
Materialise (Euronext & Nasdaq: MTLS) announced the start of an additional listing of its ordinary shares on Euronext Brussels, effective November 20, 2025, to complement its Nasdaq ADS listing. The company named KBC Securities as listing agent and Euroclear as issuer CSD.
Founders Fried Vancraen and Hilde Ingelaere may sell up to 590,000 shares (~1% of outstanding) via a trading arrangement while retaining ownership and may buy ADSs on Nasdaq in anticipation of sales.
Key capital figures: total capital €4,487,050.49, 59,067,186 shares carrying voting rights, 90,712,021 total voting rights (reflecting newly introduced double voting rights), and 350,000 subscription rights.
Materialise (NASDAQ: MTLS) announced the results of its Extraordinary Shareholders’ Meeting held on November 14, 2025. All proposed resolutions presented at the meeting were approved by the shareholders.
For full voting tallies and additional documentation, investors are directed to the company’s investor website.
Materialise (NASDAQ:MTLS) will hold an Extraordinary Shareholders’ Meeting on Friday, November 14, 2025 at 17:00 CET at its registered office in Leuven and digitally executed by a notary in Ghent.
Agenda items include proposals for share capital movements, a potential buyback program and a new board authorization for buybacks, amendments to the articles of association including the introduction of double voting rights, approval of the remuneration policy, mandating the statutory auditor for sustainability assurance, and confirmation of board composition and director qualifications.
Decisions are partly subject to conditions tied to completion of the listing and other transactions. Documents and convening notices are available on Materialise's website.
Materialise (Nasdaq: MTLS) announced plans for an additional listing of its ordinary shares on Euronext Brussels and an ADS buyback program of up to EUR 30 million. The Euronext listing is expected on or around November 20, 2025 and will complement the existing Nasdaq ADS listing to broaden the investor base and provide liquidity and operational flexibility. The ADS buyback was approved by the board on October 27, 2025, may repurchase approximately 6.1 million ADSs based on the Oct 28, 2025 close, is subject to shareholder approval on November 14, 2025, and is expected to be initiated by no later than January 2026 with execution within 12 months.
Materialise (NASDAQ:MTLS) reported Q3 2025 results for the quarter ended September 30, 2025. Total revenue was 66,259 kEUR, down 3.5% year-over-year but up 2.2% from Q2 2025. Materialise Medical revenue set a quarterly record at 33,296 kEUR, +10.3% YoY. Adjusted EBIT was 2,918 kEUR (4.4% margin) and net profit was 1,848 kEUR (EUR 0.03 per diluted share). Cash and cash equivalents were 132,022 kEUR with gross debt of 64,278 kEUR, producing a net cash position of 67,744 kEUR (increase of 6,724 kEUR since Dec 31, 2024). Full-year 2025 revenue guidance remains 265,000–280,000 kEUR and Adjusted EBIT guidance unchanged at 6,000–10,000 kEUR.
Materialise (NASDAQ: MTLS) will report third quarter 2025 results for the period ended September 30, 2025 on Tuesday, October 28, 2025 at 6:30 a.m. ET / 11:30 a.m. CET. Senior management will host a conference call to discuss results on October 28, 2025 at 8:30 a.m. ET / 1:30 p.m. CET.
Investors can join the call by phone (dial-in details provided via the link at least 15 minutes before start time) or listen to a live audio webcast at http://investors.materialise.com. The webcast will be archived on the company website for later access.
Materialise (NASDAQ:MTLS), a leader in additive manufacturing and medical software, reported mixed Q2 2025 financial results. Total revenue decreased 5.8% to 64,831 kEUR, though the Medical segment grew 16.7%. Gross profit margin improved to 58.3% from 57.0% year-over-year.
The company's Adjusted EBIT improved to 3,058 kEUR from 646 kEUR in Q1 2025 but remained below Q2 2024's 3,872 kEUR. Net profit was 199 kEUR, significantly impacted by unfavorable exchange rates. The company maintains a strong balance sheet with 63,045 kEUR in net cash.
Due to geopolitical volatility and economic uncertainty, Materialise revised its 2025 revenue guidance to 265,000-280,000 kEUR but maintained its Adjusted EBIT guidance of 6,000-10,000 kEUR.
Materialise (NASDAQ: MTLS), a leader in additive manufacturing software and 3D printing services, has scheduled its Q2 2025 earnings release for July 24, 2025 at 6:30 a.m. ET.
The company will host a conference call with senior management to discuss the results at 8:30 a.m. ET on the same day. Participants can access the call through a dial-in option or receive a callback. Additionally, a live audio webcast will be available through the investor relations website, with an archived version accessible afterward.
Materialise (NASDAQ:MTLS), a leading additive manufacturing software and 3D printing solutions provider, has announced its upcoming Annual General Shareholders' Meeting (AGM) scheduled for June 3, 2025, at 10:00 am CET. The company will also hold an Extraordinary Shareholders' Meeting on the same date to vote on proposed amendments to its articles of association. The key proposals include:
- Renewal of Board of Directors' authorization to increase authorized share capital
- Modification of the statutory AGM date starting in 2026
All relevant documents, including the annual report and meeting notices, are accessible on the company's investor relations website.
FAQ
What is the current stock price of Materialise (MTLS)?
What is the market cap of Materialise (MTLS)?
